Uncategorized

Northwind Pharmaceuticals

Northwind Pharmaceuticals provides pharmaceuticals to clinics for in-office dispensing.  Founded in 1981, Northwind offers a variety of products to physicians interested in providing medication dispensing services to patients.  Based in Indianapolis, Indiana, Northwind is centrally located for quick shipping to locations across the United States.

Here is a summary of our offerings:

  • Prepackaged pharmaceuticals – bulk product repackaged into unit-of-use sizes for physician dispensing.
  • Injectables
  • Lotions, creams, ointments
  • Liquids
  • Medical Supplies

You can view a complete list of our pharmaceuticals and medical supplies in our online catalog.

Northwind offers two dispensing systems to clinics interested in pharmaceutical dispensing.  Our manual system uses carbon labels to capture patient information and medication instructions.  The labels are kept in a logbook for accurate record keeping.  We also offer RxTracker, a web-based system which allows clinics to track inventory, print patient labels and reorder electronically.  Both systems are offered at no-charge to Northwind Pharmaceuticals customers.

We make ordering easy.  Clinics can order through our online catalog, send us an email, fax their order or call our toll free number.  We accept orders 24 hours a day and most products are shipped the same day the order is received.

For more information, please visit us at www.nwpharma.com.  You can also call us at 800.722.0772 or email info@nwpharma.com.

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading